首页> 外文期刊>Heartdrug: excellence in cardiovascular trials >Right Heart Catheterization: Indications, Technique, Safety, Measurements, and Alternatives
【24h】

Right Heart Catheterization: Indications, Technique, Safety, Measurements, and Alternatives

机译:右心导管插入:适应症,技术,安全,测量和替代方案

获取原文
获取原文并翻译 | 示例
           

摘要

For over three decades, balloon-tipped right heart catheterization (RHCn) has been employed to assist in the diagnosis, assessment, and management of high-risk patients and interventions. There has been a considerable debate regarding the safety and efficacy of this clinical tool, and even moratorium has been suggested. Currently, even in the face of contemporary noninvasive methods to obtain hemodynamic data, RHCn is still utilized. However, quality randomized clinical trials, assessing the effects RHCn on outcome of well-defined patient's subsets, are clearly lacking. The contemporary indications, technique, and safety issues are discussed. Accurate data acquisition and interpretation are emphasized. Finally, RHC data are compared with hemodynamic information obtained noninvasively by impedance cardiography (ICG), and echocardiograpy and Doppler analysis. Recently, modern pump-function descriptor (cardiac power) derived from cardiac output measurements have emerged. The important interplay between the systemic and pulmonary circulation became increasingly acknowledged. Although modern right heart catheters (RHCs) are able to provide comprehensive, continuous, real-time, and effort-free hemodynamic data, they did not replace the 30-year-old inexpensive RHCs. Regrettably, no noninvasive alternatives can provide all these features. Our educational goals should include more appropriate case selection, along with safer insertion and reliable data acquisition and interpretation. The industry should attempt to incorporate into the monitored intensive care bed, safer systems and devices that provide continuous, 'hands-off', low maintenance, comprehensive and accurate hemodynamic data. RHCn is still an excellent and most comprehensive clinical and research method for hemodynamic assessment and monitoring. It is likely to continue to play a pivotal role in modern intensive care as well as contemporary research. In clinical practice, case selection for RHCn should be based on the clinical questions and dilemmas the patient is presenting. In research, RHCn should be employed whenever noninvasive methods could not reliably obtain data that are required to answer the scientific question.
机译:三十年来,一直使用气球尖端的右心导管插入术(RHCN)来协助高危患者和干预措施的诊断,评估和管理。关于该临床工具的安全性和有效性,已经提出了很多争论,甚至提出了暂停。目前,即使面对当代无创方法获得血液动力学数据,RHCN仍被利用。但是,显然缺乏质量的随机临床试验,评估RHCN对明确定义患者子集结果的影响的影响。讨论了当代的迹象,技术和安全问题。强调了准确的数据获取和解释。最后,将RHC数据与通过阻抗心脏摄影(ICG)以及超声心动恐怖和多普勒分析获得无创获得的血液动力学信息进行了比较。最近,出现了从心输出测量中得出的现代泵功能描述符(心功率)。系统性和肺循环之间的重要相互作用越来越多地得到认可。尽管现代的右心导管(RHC)能够提供全面,连续,实时和无努力的血液动力学数据,但它们并没有取代30岁的廉价RHC。遗憾的是,没有无创替代方案可以提供所有这些功能。我们的教育目标应包括更合适的案例选择,以及更安全的插入和可靠的数据获取和解释。该行业应尝试将其纳入受监控的重症监护床,更安全的系统和设备,以提供连续,“失效”,低维护,全面和准确的血液动力学数据。 RHCN仍然是血液动力学评估和监测的出色,最全面的临床和研究方法。它很可能会继续在现代重症监护和当代研究中发挥关键作用。在临床实践中,RHCN的病例选择应基于患者所呈现的临床问题和困境。在研究中,每当无创方法无法可靠地获得回答科学问题所需的数据时,应采用RHCN。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号